急性脑损伤与非急性脑损伤患者撤销或不予维持生命治疗决策:两项前瞻性队列研究的二次分析
该研究为两项前瞻性国际研究的二次分析,纳入2004至2016年40个国家21 970例接受有创或无创通气的患者,其中16 791例纳入撤销或不予维持生命治疗分析。急性脑损伤定义为脑创伤、缺血性卒中、颅内出血、癫痫发作或脑膜脑炎。急性脑损伤患者撤销或不予维持生命治疗发生率为17.0%(372/2191),非急性脑损伤患者为11.5%(1684/14 600),风险差5.5%(95%CI 3.8-7.1),OR 2.42(95%CI 1.89-3.12)。急性脑损伤患者决策时间更早(中位4天 vs 6天,绝对差2天,95%CI 1-3)。各ICU间决策差异大(中位OR分别为3.04和2.59)。
要点
- 急性脑损伤患者撤销或不予维持生命治疗发生率为17.0%(372/2191),非急性脑损伤患者为11.5%(1684/14 600),OR 2.42(95%CI 1.89-3.12)。
- 急性脑损伤患者撤销或不予维持生命治疗决策时间更早:中位4天(IQR 2-9) vs 非急性脑损伤6天(IQR 2-13),绝对差2天(95%CI 1-3)。
- 不同急性脑损伤亚组、世界区域和队列年份结果相似。
- ICU间撤销或不予维持生命治疗决策差异大:急性脑损伤患者中位OR 3.04(95%CI 2.54-3.67),非急性脑损伤患者中位OR 2.59(95%CI 2.38-2.78)。
- 作者认为急性脑损伤后早期撤销或不予维持生命治疗的理由需进一步探究,需考虑本分析未纳入的其他神经学因素。
适用人群与场景
- 两项前瞻性国际研究纳入的2004至2016年40个国家接受有创或无创通气的患者。
- 急性脑损伤定义为脑创伤、缺血性卒中、颅内出血、癫痫发作或脑膜脑炎;对照组为非急性脑损伤疾病。
诊断标准与关键阈值
- 急性脑损伤定义:脑创伤、缺血性卒中、颅内出血、癫痫发作或脑膜脑炎。
研究设计与关键结果
- 研究类型:两项前瞻性国际研究的二次分析,纳入21 970例患者(16 791例纳入撤销或不予维持生命治疗分析),来自40个国家,招募时间2004年3月11日至2016年12月17日。
- 人群特征:13 526例(61.6%)男性,8444例(38.4%)女性,2896例(13.2%)有急性脑损伤。
- 主要结果:撤销或不予维持生命治疗在2056/16 791例(12.2%)中发生;急性脑损伤患者372/2191例(17.0%) vs 非急性脑损伤患者1684/14 600例(11.5%),风险差5.5%(95%CI 3.8-7.1),OR 2.42(95%CI 1.89-3.12)。
- 时间结果:急性脑损伤患者撤销或不予维持生命治疗决策中位4天(IQR 2-9) vs 非急性脑损伤患者6天(IQR 2-13),绝对差2天(95%CI 1-3)。
- 亚组与区域:不同急性脑损伤亚组、世界区域和队列年份结果相似。
- ICU间差异:急性脑损伤患者中位OR 3.04(95%CI 2.54-3.67),非急性脑损伤患者中位OR 2.59(95%CI 2.38-2.78)。
证据类型、等级与局限
- 证据类型:两项前瞻性国际队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急性脑损伤后早期撤销或不予维持生命治疗的理由需进一步探究,需考虑本分析未纳入的其他神经学因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Many deaths in the intensive care unit (ICU) occur after a decision to withdraw or withhold life-sustaining therapies (WLSTs). We aimed to explore the differences in the incidence and timing of WLST between patients with and without acute brain injuries (ABIs).
METHODS: We did a secondary analysis of two prospective, international studies that recruited patients who were invasively or non-invasively ventilated between 2004 and 2016 from 40 countries. ABI was defined as brain trauma, ischaemic stroke, intracranial haemorrhage, seizures, or meningitis-encephalitis. The comparator group included non-ABI conditions. Time to WLST was evaluated by use of cumulative incidence curves. Differences in WLST were analysed by use of multilevel logistic regression.
FINDINGS: Between March 11, 2004, and Dec 17, 2016, we recruited 21 970 patients (16 791 in the WLST analysis), of whom 13 526 (61·6%) were male and 8444 (38·4%) were female and 2896 (13·2%) had ABI. WLST occurred in 2056 (12·2%) of 16 791 patients) and was more common in patients with ABI versus without (372 [17·0%] of 2191 vs 1684 [11·5%] of 14 600; risk difference 5·5%; 95% CI 3·8-7·1; odds ratio [OR] 2·42; 1·89-3·12). WLST decisions occurred earlier in patients with ABI versus patients without ABI (median, 4 days [IQR 2-9] versus 6 days [2-13] after ICU admission; absolute difference, 2 days; 95% CI 1-3). Findings were similar across different ABI subgroups, world regions, and cohort years. Variability among ICUs in WLST decisions for patients with ABI and patients without ABI was high (respectively, median OR, 3·04; 95% CI 2·54-3·67, and median OR 2·59; 2·38-2·78).
INTERPRETATION: Our findings suggest that WLST decisions are significantly more common in patients with ABI versus patients without ABI and occur earlier in this group. The rationale for early WLST following ABI warrants further exploration, accounting for additional neurological factors that were not available in the present analysis.
FUNDING: Canadian Institutes of Health Research.
参考来源
- Taran S, Liu K, McCredie VA, et al. Decisions to withdraw or withhold life-sustaining therapies in patients with and without acute brain injury: a secondary analysis of two prospective cohort studies. Lancet Respir Med. 2025. PMID: 40112845. doi:10.1016/S2213-2600(24)00404-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。